IMI PLC
04 August 2026
4 August 2026
IMI PLC
NOTIFICATION OF ADMISSION OF FURTHER SECURITIES TO TRADING
Further to IMI plc's ("IMI" or the "Company") Issue of Equity announcement on 3 August 2026 in respect of the allotment of Ordinary Shares and following the admission to trading of those Ordinary Shares, the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.
|
1 |
Details of the issuer |
|
|
a) |
Name |
IMI PLC |
|
b) |
LEI |
2138002W9Q21PF751R30 |
|
2 |
Details of the transferable securities admitted to trading |
|
|
a) |
Name, type and identification code |
Ordinary Shares of 28 4/7 pence each ISIN: GB00BGLP8L22 |
|
b) |
Regulated market |
London Stock Exchange - Main Market |
|
c) |
Number of further securities admitted to trading covered by this notification |
195,831 |
|
d) |
Total number of securities admitted to trading following admission |
250,564,187 |
|
e) |
Fungibility |
Fully fungible with existing Ordinary Shares |
|
3 |
Admission details |
|
|
a) |
Date of admission |
4 August 2026 |
|
a) |
Date range covered by the notification |
Admission of shares under the Company's US Stock Purchase Plan from 22 August 2018 up to 24 June 2026, admitted to trading on the Main Market of the London Stock Exchange |
|
b) |
Prospectus information |
N/A |
For further information, please contact:
Louise Waldek
Company Secretary
0121 717 3700
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.